BH-30643 clinical trials

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

This study is testing a new medicine called BH-30643 for a type of advanced lung cancer. It aims to see if it's safe, how well it works, and what dose is best for people with specific gene changes in their cancer.